Companies / Oramed Pharmaceuticals Inc. / Activity

Activity — Oramed Pharmaceuticals Inc.

36 moves.

Date	Actor	Action	Security	Value	Shares Δ	Position after	Impact
Mar 30, 2026	Kidron Miriam Executive	Other	Common Stock	$1.44M	-435K -27.74%	1,133,138 2.72% of shares	low
Mar 30, 2026	Kidron Nadav CEO	Other	Common Stock	$148.3K	-45K -1.29%	3,422,243 8.23% of shares	low
Mar 17, 2026	Gabay Avraham Executive	Grant	Common Stock	$0	+96K +14.77%	745,145 1.79% of shares	low
Jan 22, 2026	Gabay Avraham Executive	Exercise	Common Stock	$0	+19K +3.01%	649,256 1.56% of shares	low
Dec 31, 2025	Gabay Avraham Executive	Grant	Common Stock	$0	+115K +22.32%	630,256 1.52% of shares	low
Dec 31, 2025	Gabay Avraham Executive	Grant	Common Stock	$0	+81K +18.71%	515,256 1.24% of shares	low
Mar 17, 2026	Hexter Joshua Executive	Grant	Common Stock	$0	+96K +9.01%	1,160,384 2.79% of shares	low
Jan 22, 2026	Hexter Joshua Executive	Exercise	Common Stock	$0	+19K +1.82%	1,064,495 2.56% of shares	low
Dec 31, 2025	Hexter Joshua Executive	Grant	Common Stock	$0	+115K +12.36%	1,045,495 2.51% of shares	low
Dec 31, 2025	Hexter Joshua Executive	Grant	Common Stock	$0	+97K +11.68%	930,495 2.24% of shares	low
Mar 17, 2026	Kidron Miriam Executive	Grant	Common Stock	$0	+120K +8.25%	1,568,222 3.77% of shares	low
Jan 22, 2026	Kidron Miriam Executive	Exercise	Common Stock	$0	+19K +1.33%	1,448,664 3.48% of shares	low
Jan 14, 2026	Kidron Miriam Executive	Gift	Common Stock	$0	-86K -6.03%	1,343,498 3.23% of shares	low
Dec 31, 2025	Kidron Miriam Executive	Grant	Common Stock	$0	+115K +8.75%	1,429,664 3.44% of shares	low
Dec 31, 2025	Kidron Miriam Executive	Grant	Common Stock	$0	+121K +10.17%	1,314,664 3.16% of shares	low
Mar 17, 2026	Kidron Nadav CEO	Grant	Common Stock	$0	+167K +5.13%	3,422,243 8.23% of shares	low
Mar 12, 2026	Kidron Nadav CEO	Gift	Common Stock	$0	-100K -2.98%	3,255,238 7.83% of shares	low
Jan 22, 2026	Kidron Nadav CEO	Exercise	Common Stock	$0	+109K +3.36%	3,355,238 8.07% of shares	low
Dec 31, 2025	Kidron Nadav CEO	Grant	Common Stock	$0	+327K +11.20%	3,246,238 7.80% of shares	low
Dec 31, 2025	Kidron Nadav CEO	Grant	Common Stock	$0	+233K +8.66%	2,919,238 7.02% of shares	low
Dec 31, 2025	Mayer Arie Director	Grant	Common Stock	—	+5K +3.00%	168,009 0.40% of shares	low
Dec 31, 2025	Mayer Arie Director	Grant	Common Stock	—	+30K +22.54%	163,109 0.39% of shares	low
Jan 22, 2026	Gabay Avraham Executive	Exercise	Performance Stock Units	—	-19K -100.00%	0 0.00% of shares	low
Dec 31, 2025	Gabay Avraham Executive	Grant	Performance Stock Units	—	+19K	19,000 0.05% of shares	low
Jan 22, 2026	Hexter Joshua Executive	Exercise	Performance Stock Units	—	-19K -100.00%	0 0.00% of shares	low
Dec 31, 2025	Hexter Joshua Executive	Grant	Performance Stock Units	—	+19K	19,000 0.05% of shares	low
Jan 22, 2026	Kidron Miriam Executive	Exercise	Performance Stock Units	—	-19K -100.00%	0 0.00% of shares	low
Dec 31, 2025	Kidron Miriam Executive	Grant	Performance Stock Units	—	+19K	19,000 0.05% of shares	low
Jan 22, 2026	Kidron Nadav CEO	Exercise	Performance Stock Units	—	-109K -100.00%	0 0.00% of shares	low
Dec 31, 2025	Kidron Nadav CEO	Grant	Performance Stock Units	—	+109K	109,000 0.26% of shares	low
Dec 31, 2025	Reznick Yehuda Director	Grant	Common Stock	—	+6K +6.32%	105,180 0.25% of shares	low
Dec 31, 2025	Reznick Yehuda Director	Grant	Common Stock	—	+30K +43.52%	98,930 0.24% of shares	low
Dec 31, 2025	Shapiro Benjamin Director	Grant	Common Stock	—	+4K +2.92%	123,220 0.30% of shares	low
Dec 31, 2025	Shapiro Benjamin Director	Grant	Common Stock	—	+30K +33.44%	119,720 0.29% of shares	low
Dec 31, 2025	Aghion Daniel Director	Grant	Common Stock	—	+6K +5.83%	113,441 0.27% of shares	low
Dec 31, 2025	Aghion Daniel Director	Grant	Common Stock	—	+30K +38.86%	107,191 0.26% of shares	low